JPMorgan Chase & Co’s Inhibikase Therapeutics IKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$55.7K Buy
+28,579
New +$55.7K ﹤0.01% 5056
2023
Q4
Sell
-5
Closed -$7 6598
2023
Q3
$7 Buy
5
+3
+150% +$4 ﹤0.01% 6370
2023
Q2
$7 Buy
+2
New +$7 ﹤0.01% 5920